Brigatinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of brigatinib that may be used in the treatment of non-small cell lung cancer (NSCLC) and inflammatory myofibroblastic tumor (IMT) with ALK translocation, uterine sarcoma, T-cell lymphomas and certain histiocytic neoplasms, such as Erdheim-Chester disease.

**Synonyms:** - Alunbrig Regimen - Brigatinib monotherapy